Biomea Fusion shares spiked on positive 52-week Phase II data for icovamenib in type 2 diabetes. Read why I rate BMEA stock a hold and remain on the sidelines.

Bunzl plc ( ($GB:BNZL) ) has issued an announcement. Bunzl plc announced the repurchase of 40,896 of its ordinary shares on the London Stock ...

Bank Of Ireland Group plc ( ($DE:BIRG) ) just unveiled an update. Bank of Ireland Group plc has announced the purchase of 100,685 of its ordinary ...

Baird Asset Management, which controls Chautauqua Capital Management, a boutique investment firm, released its second quarter ...

Q2 2025 Earnings Call September 24, 2025 7:00 AM EDTCompany ParticipantsKatherine Roe - CEO & DirectorSue Rivett - ...

Industrial control systems have grown increasingly complex, requiring faster response times, more adaptability, and seamless integration with digital ...

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. Royalty Pharma plc is one of them. Royalty Pharma plc (NASDAQ:RPRX) tops our list for being one of ...

VivoPower expands partnership with Crypto.com-Offers bonus XRP tokens through shareholder benefits program VivoPower shareholders who sign up with Crypto.com can receive $100 bonus of XRP tokens ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from CRH plc ( ...

The Board of Directors of Kojamo plc ("Kojamo" or the "Company") has decided to initiate a share buyback program based on the authorization granted by the Annual General Meeting held on 13 March 2025.